Search

Your search keyword '"Olivier Epaulard"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Olivier Epaulard" Remove constraint Author: "Olivier Epaulard"
165 results on '"Olivier Epaulard"'

Search Results

1. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

2. Cytomegalovirus detection is associated with ICU admission in non-AIDS and AIDS patients with Pneumocystis jirovecii pneumonia.

3. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohortResearch in context

4. COVID-19 mass vaccination – an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns

5. 'When did you decide to receive the Covid-19 vaccine?' Survey in a high-volume vaccination center

6. Mandatory vaccination in France: perception by outpatients and self-evaluation of its impact on their vaccine confidence

7. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

8. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

9. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome

10. Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial

11. Virological Markers in Epstein–Barr Virus-Associated Diseases

12. Screening of hepatitis E in patients presenting for acute neurological disorders

13. Behavior of nurses and nurse aides toward influenza vaccine: the impact of the perception of occupational working conditions

14. Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality

15. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella

16. Hepatic Brucelloma Diagnosis and Long-Term Treatment, France

17. Added Value of Next-Generation Sequencing for Multilocus Sequence Typing Analysis of a Pneumocystis jirovecii Pneumonia Outbreak

18. Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France

19. Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation.

20. Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016.

21. Vaccine eagerness: A new framework to analyse preferences in single profile discrete choice experiments. Application to HPV vaccination decisions among French adolescents

22. Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic

23. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

24. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

25. Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use

26. Epidemiology and outcome of occult bacteremia in patients discharged from emergency departments or ambulatory units: one-year study

27. Characteristics, management, and outcomes of patients with infectious encephalitis requiring intensive care: A prospective multicentre observational study

28. 'When did you decide to receive the Covid-19 vaccine?' Survey in a high-volume vaccination center

29. The onset of late severe lung impairment in COVID-19 is associated with high inflammation markers at admission and metabolic syndrome markers

30. Changer de focale pour agir sur une épidémie transfrontalière. Le VIH à la frontière franco-suisse

31. Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results

32. Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1)

34. Author response for 'Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients'

35. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients

36. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

37. SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

38. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

39. Symptoms and severity in vaccinated and unvaccinated patients hospitalised with SARS-CoV-2 delta (B.1.617.2) variant infection

40. Vaccine eagerness: A new framework to analyse preferences in single profile discrete choice experiments. Application to HPV vaccination decisions among French adolescents

41. Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians

42. Letermovir use to treat complex cytomegalovirus reactivations in two heart transplant recipients

44. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

45. Author response for 'Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study'

46. Fine analysis of lymphocyte subpopulations in SARS-CoV-2 infected patients: toward a differential profiling of patients with severe outcome

47. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

48. A Prospective Cohort Study to Identify Clinical, Biological, and Imaging Features That Predict the Etiology of Acute Encephalitis

49. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

50. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort

Catalog

Books, media, physical & digital resources